[Therapy with corticosteroids].
D000303:Adrenal Cortex Diseases / Q000139:chemically induced; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000893:Anti-Inflammatory Agents; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000139:chemically induced; D005943:Gluconeogenesis / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D007165:Immunosuppression Therapy; D008901:Mineralocorticoids / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D008968:Molecular Conformation; D013810:Therapeutic Equivalency
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D008901:Mineralocorticoids; D000324:Adrenocorticotropic Hormone
Therapie mit Kortikosteroiden.